About us Contact Terms of Use Data Sources Publications FAQ
MAP2K4 logo

MAP2K4

Dual specificity mitogen-activated protein kinase kinase 4

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.03 1.87 1.78 1.71 1.47 126 1.98 1.86 1.81 1.77 -0.09 -0.03
Bladder (BLCA) 406 2.21 1.81 1.73 1.65 1.02 9 1.84 1.79 1.76 1.69 1.68 -0.03
Breast (BRCA) 1067 2.40 1.88 1.77 1.68 0.91 178 1.82 1.72 1.69 1.66 1.57 0.08
Cervical (CESC) 297 1.99 1.78 1.71 1.62 1.04 10 2.00 1.90 1.74 1.71 1.64 -0.03
Cholangiocarcinoma (CHOL) 36 1.96 1.81 1.73 1.67 1.48 0
Colon (COAD) 443 2.07 1.76 1.67 1.59 0.65 166 1.84 1.71 1.67 1.63 -0.09 0.01
B-cell lymphoma (DLBC) 42 2.04 1.82 1.76 1.70 1.60 337 2.51 2.11 1.98 1.81 1.27 -0.22
Esophageal (ESCA) 142 2.21 1.82 1.75 1.67 1.47 271 2.09 1.95 1.89 1.83 -0.09 -0.14
Glioblastoma (GBM) 160 2.00 1.78 1.73 1.68 1.45 214 2.53 2.02 1.97 1.92 -0.09 -0.24
Head and neck (HNSC) 432 2.45 1.97 1.87 1.80 1.42 55 2.02 1.74 1.69 1.66 1.54 0.18